Current status of radioimmunoimaging and radioimmunotherapeutic antibody drugs
10.3760/cma.j.issn.2095-2848.2016.02.024
- VernacularTitle:用于放射免疫显像和治疗的抗体药物研究现状
- Author:
Yonglong ZENG
;
Qimin DENG
;
Yuanyuan LIU
;
Bangjin WANG
- Publication Type:Journal Article
- Keywords:
Radioimmunodection;
Radioimmunotherapy;
Antibodies,monoclonal;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2016;36(2):196-200
- CountryChina
- Language:Chinese
-
Abstract:
Radiolabeled monoclonal antibodies can specifically bind to tumor-associated antigens.On this immune basis,RIT and RII have therefore been used in the diagnosis and treatment of cancer.Many RIT and RII pharmaceuticals were applied in trials of preclinical and clinical phases,and excellent results had been achieved.This paper reviews on the current status of RIT and RII pharmaceuticals.
